Indicative Equity Value Per Share — OUNCE SACHS $0.0753

OUNCE SACHS / GLOBAL GROUP

NEWS

Latest from Ounce Sachs

Latest from Ounce Sachs

Latest from Ounce Sachs

Corporate developments, scientific progress and selected updates from across Ounce Sachs and its Houses.

Corporate developments, scientific progress and selected updates from across Ounce Sachs and its Houses.

ALL NEWS CORPORATE SCIENCE & INNOVATION HOUSES CAPITAL MARKETS

ALL NEWS CORPORATE SCIENCE & INNOVATION HOUSES CAPITAL MARKETS

REVERSE CHRONOLOGICAL ORDER

REVERSE CHRONOLOGICAL ORDER

Institutional architecture at dusk

CAPITAL MARKETS

Following a decade of development across formulation science, intellectual property and specialist Houses, Ounce Sachs is entering its next phase with a private-capital strategy focused on commercialisation, institutional development and long-term growth.

Following a decade of development across formulation science, intellectual property and specialist Houses, Ounce Sachs is entering its next phase with a private-capital strategy focused on commercialisation, institutional development and long-term growth.

Open report on a dark surface

CORPORATE

An independent valuation completed on 2 August 2026 assessed the Ounce Sachs portfolio at approximately US$37.66 million, providing an independent reference point for the Group’s intellectual-property and brand portfolio as it enters its next stage of development.

An independent valuation completed on 2 August 2026 assessed the Ounce Sachs portfolio at approximately US$37.66 million, providing an independent reference point for the Group’s intellectual-property and brand portfolio as it enters its next stage of development.

OUNCE SACHS

OUNCE SACHS

A global healthcare, personal care and consumer brand group.

A global healthcare, personal care and consumer brand group.

© 2026 OUNCE SACHS

© 2026 OUNCE SACHS